For instance, programmed-cell-death-ligand (PD-L1) expression on TAMs has been demonstrated to be elevated in both mouse models and tumor tissues from patients with CCA, suggesting that TAMs may suppress cytotoxic-T-lymphocyte (CTL) activity through PD-1/PD-L1 interaction [42]. The gene discussed is CD274; the disease is cholangiocarcinoma.